Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-028466

INTERIM CEO gave up 68,343 shares (to pay taxes)

  • INTERIM CEO acquired 118,840 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal INTERIM CEO 2024-12-04 Option exercise +118,840 $1.52 $180,637 1,501,973 D
Walker Neal INTERIM CEO 2024-12-04 Shares withheld for taxes −68,343 $3.76 $256,970 1,433,630 D
Derivatives
Walker Neal INTERIM CEO 2024-12-04 Option exercise · Employee Stock Option (right to buy) −118,840 0 D
Loading xslF345X05/form4-12062024_041206.xml…